Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Favrot

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Pathologie-Biologie|January 1, 1988
[Cell cultures in Burkitt's lymphoma. Detection of residual disease and application to autologous graft purging]I Philip, M Favrot
Experimental Hematology|January 1, 1990
Lectin-binding properties of Burkitt's lymphoma cell lines: application to bone marrow purgingM Mumcuoglu, M Favrot, S Slavin
Bulletin Du Cancer|January 1, 1992
[To break the isolation. Telecommunication to help the schooling of sick children]M Favrot, D Frappaz, P Saltel, et al.
Pediatrie|January 1, 1989
[Cytokines and their receptors networks: biology and therapeutic possibilities]M Favrot, S Negrier, V Combaret, et al.
Bulletin Du Cancer|January 1, 1990
[Role of massive chemotherapy and bone marrow graft in the treatment of non-Hodgkin's lymphoma]E Bouffet, M Favrot, P Biron, et al.
Blood|October 27, 1998
Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cellsN Voorzanger-Rousselot, M Favrot, J Y Blay
Journal De Genetique Humaine|December 1, 1984
[An all-inclusive genetic theory for carcinogenesis?]T Philip, I Philip, M Favrot, et al.
Gene Therapy|September 25, 1998
Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapyM Favrot, J L Coll, N Louis, et al.
Pediatrie|January 1, 1992
[Gene transfer and gene therapy]Y Merrouche, V Combaret, S Négrier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Burkitt's lymphoma: a model for clinical oncologyE Bouffet, D Frappaz, R Pinkerton, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Pathologie-Biologie|January 1, 1988
[Cell cultures in Burkitt's lymphoma. Detection of residual disease and application to autologous graft purging]I Philip, M Favrot
Experimental Hematology|January 1, 1990
Lectin-binding properties of Burkitt's lymphoma cell lines: application to bone marrow purgingM Mumcuoglu, M Favrot, S Slavin
Bulletin Du Cancer|January 1, 1992
[To break the isolation. Telecommunication to help the schooling of sick children]M Favrot, D Frappaz, P Saltel, et al.
Pediatrie|January 1, 1989
[Cytokines and their receptors networks: biology and therapeutic possibilities]M Favrot, S Negrier, V Combaret, et al.
Bulletin Du Cancer|January 1, 1990
[Role of massive chemotherapy and bone marrow graft in the treatment of non-Hodgkin's lymphoma]E Bouffet, M Favrot, P Biron, et al.
Blood|October 27, 1998
Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cellsN Voorzanger-Rousselot, M Favrot, J Y Blay
Journal De Genetique Humaine|December 1, 1984
[An all-inclusive genetic theory for carcinogenesis?]T Philip, I Philip, M Favrot, et al.
Gene Therapy|September 25, 1998
Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapyM Favrot, J L Coll, N Louis, et al.
Pediatrie|January 1, 1992
[Gene transfer and gene therapy]Y Merrouche, V Combaret, S Négrier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Burkitt's lymphoma: a model for clinical oncologyE Bouffet, D Frappaz, R Pinkerton, et al.
Pageof 7